Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

COVID-19: Answering the Questions, Part 13

In Part 13 of this ongoing COVID-19 series, listen to a brief update on monoclonal antibody treatments for COVID-19 and the recently released COVID-19 vaccine efficacy information from Jens D. Lundgren, MD, DMSc.
Jens D. Lundgren, MD, DMSc
Released: December 8, 2020

In this episode, Part 13 of an ongoing series, Jens D. Lundgren, MD, DMSc, provides a brief update monoclonal antibody treatments for COVID-19, including the FDA Emergency Use Authorization for bamlanivimab and discusses the recently released information on COVID-19 vaccine efficacy. After the update, Professor Lundgren answers clinician questions on various aspects of COVID-19. 

Presenter:

Jens D. Lundgren, MD, DMSc
Professor
Rigshospitalet, University of Copenhagen
Copenhagen, Denmark
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospitalet, University of Copenhagen
Copenhagen, Denmark

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Educational grant provided by
Gilead Sciences, Inc.

Related Content

Download free slides from CCO reviewing the latest data and guidance on COVID-19 symptoms and the prevalence and duration of natural immunity

Ada Adimora, MD, MPH David Heymann, BA, MD, DTM&H Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Jens D. Lundgren, MD, DMSc Vikramjit Mukherjee, MD Roger Paredes, MD, PhD Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: March 26, 2021

Download free slides from CCO reviewing the latest data and guidance on COVID-19 risk and management in special populations and persons with comorbidities

Ada Adimora, MD, MPH David Heymann, BA, MD, DTM&H Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Jens D. Lundgren, MD, DMSc Vikramjit Mukherjee, MD Roger Paredes, MD, PhD Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: March 26, 2021

Download free slides from CCO reviewing the latest updates on COVID-19 epidemiology and emerging data on diagnosis and transmission

Ada Adimora, MD, MPH David Heymann, BA, MD, DTM&H Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Jens D. Lundgren, MD, DMSc Vikramjit Mukherjee, MD Roger Paredes, MD, PhD Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: March 26, 2021

Download free slides from CCO reviewing the latest data and guidance on COVID-19 treatments, including authorized and investigational agents

Ada Adimora, MD, MPH David Heymann, BA, MD, DTM&H Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Jens D. Lundgren, MD, DMSc Vikramjit Mukherjee, MD Roger Paredes, MD, PhD Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: March 26, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue